Evidence map›Paper›PMID 7583454›Full record

ReviewJournal of molecular medicine (Berlin, Germany)1995

Inositol phosphates in the heart: controversy and consensus.

E A Woodcock

Abstract readReview
PubMed Publisher
In one paragraph

Review in Journal of molecular medicine (Berlin, Germany), 1995. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
1.0field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 14 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

E A WoodcockCellular Biochemistry Laboratory, Baker Medical Research Institute, Prahran, Melbourne, Australia.
Baker Engineering (United States) · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Numerous studies have addressed various aspects of inositol phosphate release and metabolism in myocardial preparations, and many different viewpoints have been expressed. The various results and interpretations presented often appear confusing and extracting a consensus view can be difficult. The differences often derive from the differing cardiac preparations used, especially isolated cells versus intact tissue. Despite these problems there are aspects where consensus prevails. Both the metabolism and the functional activity of inositol phosphates in heart appear to differ from those previously described in non-excitable cells. Inositol phosphates do not appear to be of major importance in the control of cardiac function under physiological conditions but may well have greater influence under pathological conditions such as myocardial ischaemia and reperfusion. Hopefully, the near future will see remaining controversies resolved.

Indexed as

AnimalsCalciumHumansInositol 1,4,5-TrisphosphateInositol PhosphatesMyocardial IschemiaMyocardial ReperfusionMyocardiumCalciumInositol 1,4,5-TrisphosphateInositol Phosphates

Identifiers

PMID7583454
OpenAlexW2005485501

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.